January 13, 2015
Last week, the United States inched closer to its first biosimilar approval. At a Wednesday meeting of the Food and Drug Administration’s Oncological Drugs Advisory Committee, panelists recommended approval for a filgrastim biosimilar.
January 12, 2015
Americans who begin 2015 with a new health care plan may soon discover the hidden costs of an insurance payment structure known as specialty tiers.
January 6, 2015
The Alliance for Patient Access released today a new policy video offering a vital prescription for safe use of biosimilars: distinct naming conventions and comprehensive testing.
December 19, 2014
Patient access encountered a range of challenges in 2014 – some old, some new. Here’s a look back at the top seven issues that drove physicians to advocate for their patients this year.
December 15, 2014
Lowering infant mortality rates begins with reducing preterm births, a recent briefing on Capitol Hill conveyed.
December 11, 2014
Under the Affordable Care Act, fewer Americans are now uninsured. So why does the government’s discount drug problem for hospitals treating uninsured patients continue to expand?
December 8, 2014
Getting patients’ medications right could save $290 million in avoidable medical spending, Terry McInnis, MD explained in a recent Patient Advocacy Leaders Summit webinar.
December 4, 2014
The National Perinatal Association’s 2015 guidelines for preventative RSV (respiratory syncytial virus) treatment send a clear message about protecting pre-term infants: the FDA indication stands.
December 2, 2014
Abuse-deterrent formulations mark a valuable step toward curbing prescription pain pill abuse, suggests a new Institute for Patient Access policy brief.
November 25, 2014
Participating in a clinical trial offers patients unprecedented access to investigative treatments – and an unparalleled opportunity to give back to society.
